European Medicines Agency updates patient and prescriber information for Pradaxa

View source ↗

Summary

EMA updates patient and prescriber information for Pradaxa to reflect new safety and usage details.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Venous Thromboembolism

Drugs mentioned

• Pradaxa (dabigatran etexilate)